In 1995, a young patient suffering from lymphoma succumbed to its radio-chemotherapeutic treatment without showing mutations in the ATM gene similar to those observed with the AT syndrome: it was later discovered that this young patient was suffering from a mutation of ligase IV (LIG4), which is essential for the NHEJ pathway [27,28,29]. This evidence concerns the gene ATM and lymphoma.